Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy.
Hung YH, Yu AL, Chen YC, Tsai CH, Su MY, Shun CT, Hsueh HW, Jyh-Ming Juang J, Lee MJ, Tseng PH, Hsu CH, Hsieh ST, Ko CL, Lin KP, Yu WC, Cheng MF, Chao CC, Lin YH. Hung YH, et al. Among authors: lee mj. J Formos Med Assoc. 2024 Oct 10:S0929-6646(24)00481-9. doi: 10.1016/j.jfma.2024.10.005. Online ahead of print. J Formos Med Assoc. 2024. PMID: 39389803 Free article.
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640
Impact of Tafamidis on [99mTc]Tc-pyrophosphate Scintigraphy in Ala97Ser Hereditary Transthyretin amyloid cardiomyopathy: significant initial reduction with stable Long-Term effects.
Yu AL, Chen YC, Tsai CH, Chao CC, Su MY, Shun CT, Hsueh HW, Juang JJ, Lee MJ, Tseng PH, Hsieh ST, Cheng MF, Lin YH. Yu AL, et al. Among authors: lee mj. Eur J Nucl Med Mol Imaging. 2025 Jan 13. doi: 10.1007/s00259-025-07079-4. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 39800807
4,247 results